Table 1 Clinical characteristics from CIDP patients with INCAT disability score, MRC sum score, and treatment history
Patient | Sex | Age | Treatment before sampling | IVIg treatment duration before d1 (months) | INCAT score d1 | INCAT score 6 months | MRC SS d1 | MRC SS 6 months | Dimer content pre-IVIg d1 (%) | Dimer content post-IVIg d1 (%) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 58 | CS | 0 | 2 | 2 | 58 | 58 | 1.3 | 3.0 |
2 | M | 62 | CS, IVIg | 9 | 2 | 2 | 58 | 58 | 3.8 | 11.3 |
3 | M | 67 | CS, IVIg | 16 | 1 | 2 | 60 | 60 | 5.4 | 5.5 |
4 | M | 34 | CS, IVIg | 10 | 1 | 2 | 52 | 52 | 2.4 | 2.4 |
5 | F | 79 | CS, IVIg | 28 | 7 | 6 | 52 | 52 | 4.6 | 9.3 |
6 | M | 61 | IVIg | 16 | 2 | 2 | 58 | 58 | 1.8 | 4.2 |
7 | M | 74 | CS, IVIg | 27 | 7 | 7 | 46 | 46 | 3.7 | 11.3 |
8 | F | 69 | IVIg | 5 | 0 | 0 | 60 | 60 | 2.7 | 6.0 |
9 | F | 73 | CS, CP | 6 | 4 | 7 | 52 | 47 | 2.3 | 4.1 |
10 | M | 48 | CS, IVIg | 6 | 3 | 1 | 58 | 58 | 2.1 | 3.4 |
11 | F | 56 | IVIg | 2 | 3 | 3 | 58 | 58 | 2.1 | 2.3 |
12 | F | 71 | IVIg | 8 | 0 | 0 | 60 | 60 | 3.9 | 7.4 |
13 | F | 79 | IVIg | 10 | 2 | 2 | 52 | 52 | 1,9 | 7,7 |
14 | M | 65 | IVIg | 10 | 2 | 2 | 58 | 58 | 0 | 4.2 |
15 | F | 78 | CS, IVIg | 12 | 1 | 1 | 58 | 58 | 3.7 | 6.2 |
16 | M | 57 | - | 0 | 2 | 2 | 60 | 60 | 0 | 3.9 |